Tag: Jublia

All

Just in Time for Summer Sandal Season: Valeant’s Jublia® Approved for Onychomycosis

The US Food and Drug Administration (FDA) has approved Jublia® (efinaconazole 10% topical solution) for the treatment of onychomycosis of the toenails.

FDA OK’S Restylane® Silk For Lip Enhancement

All

Sorry, No Posts Found

All

FDA Clears Restylane Contour for Temple Hollowing

The expanded indication is based on clinical data showing high responder rates and results lasting up to 18 months, with no serious adverse events reported.

Dexlevo Showcases PCL Collagen Stimulator Data at IMCAS 2026
FDA Approves Icotyde for Moderate-to-Severe Plaque Psoriasis
Allergan Aesthetics Introduces Skin Quality Index to Standardize Patient-Provider Communication

Tag: Jublia

All

Just in Time for Summer Sandal Season: Valeant’s Jublia® Approved for Onychomycosis

FDA OK’S Restylane® Silk For Lip Enhancement

All

Sorry, No Posts Found

All

FDA Clears Restylane Contour for Temple Hollowing

Dexlevo Showcases PCL Collagen Stimulator Data at IMCAS 2026

FDA Approves Icotyde for Moderate-to-Severe Plaque Psoriasis

Allergan Aesthetics Introduces Skin Quality Index to Standardize Patient-Provider Communication

Sorry, No Posts Found

Plastic Surgery Practice

Our Parent Company

Key Resources

Helpful Links